
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes

2 days ago
2 days ago
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Moreau
- Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below
Clinical themes
- Approved BCMA-directed therapeutic approaches
- Practical application of BCMA-directed therapies
- Future of treating RRMM: Emerging BCMA-directed therapies and combinations
The internationally renowned multiple myeloma expert faculty
- Prof. Philippe Moreau: Nantes, France
- Prof. Hermann Einsele: Würzburg, Germany
- Dr Paola Neri: Calgary, AB, Canada
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com

5 days ago
5 days ago
touchEXPERT FOCUS for touchDERMATOLOGY
Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.
The expert:
- Prof. Ilona Frieden, University of California, San Francisco, CA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc.
This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA).
For further information visit our website:

Thursday Jun 26, 2025
Thursday Jun 26, 2025
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
- Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
- Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/

Wednesday Jun 25, 2025
Wednesday Jun 25, 2025
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.
The experts:
- Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
- Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
- Prof. Peter Schmid – Barts Cancer Institute, London, UK
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:

Monday Jun 23, 2025
Monday Jun 23, 2025
touchEXPERT FOCUS for touchRESPIRATORY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
- Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/

Monday Jun 23, 2025
Monday Jun 23, 2025
touchEXPERT FOCUS for touchONCOLOGY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
- Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchoncologyime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/

Thursday Jun 19, 2025
Thursday Jun 19, 2025
NEW touchCASES for touchINFECTIOUS DISEASES
Listen to Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation.
The experts:
- Prof. José Arribas, University Hospital La Paz, Madrid, Spain,
- Ms Harriet Langanke, GSSG, Cologne, Germany
This touchPODCAST is for HCPs outside of the UK
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchinfectiousdiseases.com

Thursday May 15, 2025
RET-positive NSCLC: Translating insights into targeted approaches
Thursday May 15, 2025
Thursday May 15, 2025
touchFOCUS for touchRESPIRATORY
In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
The expert:
- Dr Christine Bestvina - University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratory.com

Thursday May 15, 2025
RET-positive NSCLC: Translating insights into targeted approaches
Thursday May 15, 2025
Thursday May 15, 2025
touchFOCUS for touchONCOLOGY
In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
The expert:
- Dr Christine Bestvina - University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com

Thursday May 08, 2025
Advances in dry eye disease: From diagnosis to new treatment targets
Thursday May 08, 2025
Thursday May 08, 2025
touchEXPERT FOCUS touchOPHTHALMOLOGY
Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today.
The expert
- Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Alcon Vision, LLC.
The activity is jointly provided by USF Health and touchIME.
For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/